Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010141570> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2010141570 endingPage "586" @default.
- W2010141570 startingPage "583" @default.
- W2010141570 abstract "An 87-year-old African-American man came to the internal medicine clinic for a routine anticoagulation management visit. He had no complaints. His medical history was significant for stage IV-A follicular non-Hodgkin's lymphoma, atrial fibrillation, and hypertension. His long-term drug therapy consisted of warfarin, felodopine, lisinopril-hydrochlorothiazide, controlled-release diltiazem, potassium chloride, and oxycodone. He reported adherence with his prescribed drugs and denied taking any over-the-counter or herbal products. Overall, the patient's drug therapy had been consistent during the preceding 3 months, no significant changes had occurred in his clinical status, and no significant changes had been noted in his diet; his international normalized ratio (INR) had ranged from 1.9–2.4 (therapeutic range 2–3). He denied tobacco use, alcohol consumption, and recent travel. Four weeks later, the patient came to the emergency department with hematuria. He denied dysuria, taking more than the prescribed amount of warfarin, any changes in his diet, taking any over-the-counter or herbal products, and any other bleeding. On admission to the hospital, his INR was 6.88, which increased to 7.29 during his hospital stay. On further investigation, the patient admitted that he had started taking an herbal supplement, royal jelly, 1 week earlier. When asked specifically about the ingredients in the supplement, he stated that royal jelly was the only component. Relative to the patient's denial of any other changes in his condition or drug regimen, the most probable explanation for his elevated INR and subsequent bleeding is a possible interaction between royal jelly and warfarin. To our knowledge, no case reports concerning royal jelly and warfarin taken concomitantly have been reported. Clinicians should be proactive and repeatedly provide education regarding the potential dangers of dietary supplements taken with conventional drugs." @default.
- W2010141570 created "2016-06-24" @default.
- W2010141570 creator A5023128941 @default.
- W2010141570 creator A5044007404 @default.
- W2010141570 date "2006-04-01" @default.
- W2010141570 modified "2023-09-27" @default.
- W2010141570 title "Warfarin and Royal Jelly Interaction" @default.
- W2010141570 cites W1514331928 @default.
- W2010141570 cites W1974116391 @default.
- W2010141570 cites W1975266016 @default.
- W2010141570 cites W1978005198 @default.
- W2010141570 cites W1985125227 @default.
- W2010141570 cites W1990015940 @default.
- W2010141570 cites W2003073742 @default.
- W2010141570 cites W2012175853 @default.
- W2010141570 cites W2031769455 @default.
- W2010141570 cites W2036864785 @default.
- W2010141570 cites W2047976786 @default.
- W2010141570 cites W2060313926 @default.
- W2010141570 cites W2088929443 @default.
- W2010141570 cites W2139972160 @default.
- W2010141570 cites W2157073178 @default.
- W2010141570 cites W2334427329 @default.
- W2010141570 cites W2432710673 @default.
- W2010141570 doi "https://doi.org/10.1592/phco.26.4.583" @default.
- W2010141570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16553520" @default.
- W2010141570 hasPublicationYear "2006" @default.
- W2010141570 type Work @default.
- W2010141570 sameAs 2010141570 @default.
- W2010141570 citedByCount "21" @default.
- W2010141570 countsByYear W20101415702012 @default.
- W2010141570 countsByYear W20101415702013 @default.
- W2010141570 countsByYear W20101415702016 @default.
- W2010141570 countsByYear W20101415702018 @default.
- W2010141570 countsByYear W20101415702019 @default.
- W2010141570 countsByYear W20101415702020 @default.
- W2010141570 countsByYear W20101415702021 @default.
- W2010141570 crossrefType "journal-article" @default.
- W2010141570 hasAuthorship W2010141570A5023128941 @default.
- W2010141570 hasAuthorship W2010141570A5044007404 @default.
- W2010141570 hasConcept C126322002 @default.
- W2010141570 hasConcept C194828623 @default.
- W2010141570 hasConcept C2776301958 @default.
- W2010141570 hasConcept C2779161974 @default.
- W2010141570 hasConcept C2780361556 @default.
- W2010141570 hasConcept C71924100 @default.
- W2010141570 hasConcept C84393581 @default.
- W2010141570 hasConceptScore W2010141570C126322002 @default.
- W2010141570 hasConceptScore W2010141570C194828623 @default.
- W2010141570 hasConceptScore W2010141570C2776301958 @default.
- W2010141570 hasConceptScore W2010141570C2779161974 @default.
- W2010141570 hasConceptScore W2010141570C2780361556 @default.
- W2010141570 hasConceptScore W2010141570C71924100 @default.
- W2010141570 hasConceptScore W2010141570C84393581 @default.
- W2010141570 hasIssue "4" @default.
- W2010141570 hasLocation W20101415701 @default.
- W2010141570 hasLocation W20101415702 @default.
- W2010141570 hasOpenAccess W2010141570 @default.
- W2010141570 hasPrimaryLocation W20101415701 @default.
- W2010141570 hasRelatedWork W131995492 @default.
- W2010141570 hasRelatedWork W1967841144 @default.
- W2010141570 hasRelatedWork W2018480046 @default.
- W2010141570 hasRelatedWork W2064495796 @default.
- W2010141570 hasRelatedWork W2319489406 @default.
- W2010141570 hasRelatedWork W2333279585 @default.
- W2010141570 hasRelatedWork W2603808924 @default.
- W2010141570 hasRelatedWork W2763816051 @default.
- W2010141570 hasRelatedWork W2889182102 @default.
- W2010141570 hasRelatedWork W4287836492 @default.
- W2010141570 hasVolume "26" @default.
- W2010141570 isParatext "false" @default.
- W2010141570 isRetracted "false" @default.
- W2010141570 magId "2010141570" @default.
- W2010141570 workType "article" @default.